CJC-1295 noDAC + Ipamorelina

SKU: CJC-IPA-10

$65.00

Disponible

MG:

5/5MG

Variante

CJC-1295 No DAC / Ipamorelin es una formulación sintética de doble péptido para investigación que combina dos péptidos reguladores de la hormona del crecimiento bien caracterizados en una única preparación analítica. CJC-1295 No DAC (Mod GRF 1-29) es un análogo de 29 aminoácidos de la hormona liberadora de la hormona del crecimiento humana (GHRH) diseñado sin la modificación del complejo de afinidad farmacológica (DAC), mientras que la Ipamorelina es un pentapéptido sintético selectivo secretagogo de la hormona del crecimiento conocido por su secuencia definida e identidad molecular. Cuando se estudian juntos, esta mezcla se utiliza comúnmente en análisis de estructura-función de péptidos, investigación de interacción de receptores y estudios de vías de señalización endocrina para evaluar comportamientos peptídicos complementarios dentro de modelos de investigación controlados. La formulación combinada se clasifica como una mezcla de múltiples péptidos en lugar de una entidad molecular única.

Product Specifications

Size: 5/5MG
Form: Lyophilized Powder
Appearance: White to off-white powder
Weight: 0.2 lb
Dimensions: 2" x 2" x 2"

COA's & Testing

Chemical Purity: >99%
Purity & Identification Testing: HPLC & Mass Spectrometry
Net Content Weight Testing: Milligram Weight
Endotoxin Testing: < 0% Bacterial Endotoxins

Regulatory & Intended Use

Regulatory Status: Solo para uso en investigación (RUO)
Chemical Grade: Laboratory, Research y Analytical

Research-Use Attestation

I confirm I am 21+ years of age or older.

I certify the information provided is true and accurate. I confirm this purchase is for laboratory research use only (not for human or animal consumption). I acknowledge the company may use IP address and other reasonable verification methods to authenticate the information provided.

Scientific Background

Discovery and Development
CJC-1295 noDAC (also known as Mod GRF 1-29) is a synthetic 29-amino-acid analog of Growth Hormone Releasing Hormone (GHRH), developed in the early 2000s as a shorter-acting version of the original CJC-1295 with Drug Affinity Complex (DAC). Ipamorelin is a selective ghrelin receptor agonist (growth hormone secretagogue) developed in the 1990s. Researchers began combining the two in the 2010s to create a synergistic blend that stimulates both GHRH and ghrelin receptors, resulting in a more robust and physiological pulsatile release of growth hormone compared to using either peptide alone.

Key Milestones in Research

Early 2000s: Development of CJC-1295 and its noDAC variant for GH research.
1990s–2000s: Discovery and characterization of Ipamorelin as a selective GH secretagogue with minimal impact on cortisol or prolactin.
2010s–Present: Widespread adoption of the CJC-1295 noDAC + Ipamorelin combination in laboratory and clinical research for studying GH/IGF-1 axis modulation, recovery, body composition, and age-related metabolic changes.

This blend remains a popular research tool because the dual stimulation of GHRH and ghrelin receptors more closely mimics natural growth hormone secretion patterns than single-agent approaches.

Why researchers choose Ceritide Research CJC-1295 noDAC + Ipamorelin Blend: High-purity synergistic combination ideal for GH/IGF-1 axis, recovery, and metabolic research.

CJC-1295 noDAC

CAS: 863288-34-0
Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight: 3367.9 g/mol
Amino Length: 29 amino acids
Classification: Growth Hormone-Releasing Hormone (GHRH) Analog
Structure: It is a linear peptide.
Sequence: Y-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
Synonyms: Modified GRF (1-29), Mod GRF 1-29, CJC-1295 without DAC, CJC-1295 no DAC
NIH PubChem: CJC-1295 noDAC (PubChem CID 91976842)
NIH PubMed Article: Jetté et al. (2005) – CJC-1295 identification study

Ipamorelin

CAS: 170851-70-4
Molecular Formula: C₃₈H₄₉N₉O₅
Molecular Weight: 711.9 g/mol
Amino Length: 5 amino acids
Classification: Selective Growth Hormone Secretagogue (GHS) / Ghrelin Receptor Agonist
Structure: A very small linear peptide.
Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Synonyms: NNC 26-0161, NNC-26-0161
NIH PubChem: Ipamorelin (PubChem CID 9831659)
NIH PubMed Article: Raun et al. (1998) – Ipamorelin selective GHS study

Storage Guidelines

Peptide Storage Guidelines: Best Practices for Research Stability

At Ceritide Research, we provide high-purity peptides for laboratory and scientific research. Proper storage preserves peptide integrity and supports reliable experimental results.

Storage Guidelines for Lyophilized (Powder) Peptides

Long-Term Storage: Keep at -20°C (-4°F) or lower (ideally -80°C / -112°F) for multi-year stability.
Short-Term Storage: Refrigerate at 2–8°C (36–46°F) for weeks to a few months. Minimize room temperature exposure.
Best Practices: Store in airtight vials with desiccants. Allow vials to reach room temperature in a desiccator before opening. Protect from light and moisture. Aliquot to reduce freeze-thaw cycles.

Storage Guidelines for Reconstituted Peptide Solutions

Once dissolved, peptides are less stable and should be used promptly:

Recommended Temperature: Store at 2–8°C (36–46°F) (refrigerator) for short-term use, typically up to 1–4 weeks depending on the sequence and buffer.
Longer-Term Solution Storage: Aliquot and freeze at -20°C (-4°F) or lower. Avoid storing solutions long-term when possible.
Best Practices: Use sterile techniques, bacteriostatic water or research-grade buffers, and minimize exposure to air and light. Prevent repeated freeze-thaw cycles.

For Research Use Only
All products from Ceritide Research are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Our peptides are intended exclusively for in vitro scientific research and are not for human or veterinary use.

Frequently Asked Questions

What makes the CJC-1295 noDAC + Ipamorelin blend different from using the peptides individually?

This blend combines two peptides that target different receptors in the growth hormone pathway. CJC-1295 noDAC acts as a GHRH analog to support pulsatile GH release, while Ipamorelin selectively stimulates ghrelin receptors. Researchers study this specific combination because the complementary mechanisms may produce a more natural and robust GH/IGF-1 response compared to either peptide used alone.

What research applications is the CJC-1295 noDAC + Ipamorelin blend commonly used for?

Researchers commonly use this blend to study synergistic effects on the growth hormone axis. It is frequently investigated in laboratory models focused on pulsatile GH release, IGF-1 regulation, metabolic function, body composition research, and tissue recovery pathways.

Can this blend be studied alongside other research peptides?

Yes. Many researchers investigate CJC-1295 noDAC + Ipamorelin in combination with other compounds as part of broader studies on the growth hormone axis and related pathways. All research should be conducted in accordance with proper laboratory protocols and safety guidelines.

Why do researchers choose the noDAC version of CJC-1295 in this blend?

The noDAC (without Drug Affinity Complex) version has a shorter half-life, which allows researchers to study more natural, pulsatile patterns of growth hormone release. This makes it particularly useful in research models aiming to mimic physiological GH secretion when combined with Ipamorelin.

Why do some researchers prefer blends over single peptides?

Blends like CJC-1295 noDAC + Ipamorelin allow researchers to study the combined effects of two complementary mechanisms in one formulation. This can simplify experimental design when investigating synergistic activity on the growth hormone axis and related pathways.

CJC-1295 noDAC + Ipamorelina

$65.00

Pago

Su información de pago está cifrada y segura.

Envío gratis

Envío gratuito a EE. UU. en todos los pedidos superiores a $250.

Servicio al Cliente

Si tiene alguna pregunta, no dude en contactarnos.

Pureza 99%+

Todos los productos se venden únicamente para fines de investigación, laboratorio o análisis, y no son aptos para el consumo humano.